Back to Search Start Over

The Analgesic and Anti-inflammatory Effects of Partially Purified Polysaccharide Fractions of Cell-free Medium and Biomass of Spirulina platensis PCST5.

Authors :
Dehghanizadeh Baghdadabad M
Naderi N
Atabaki V
Faramarzi MA
Tabarzad M
Hosseinabadi T
Source :
Iranian journal of pharmaceutical research : IJPR [Iran J Pharm Res] 2023 Jul 19; Vol. 22 (1), pp. e136661. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Publication Year :
2023

Abstract

Background: Spirulina is a cyanobacteria species containing various bioactive compounds. Spirulina is a known source of nutrients in some traditional diets. Different activities have been reported for various extracts of S. platensis .<br />Objectives: In this study, the polysaccharide content of culture media and biomass extract of one species of Spirulina was partially purified, and its analgesic and anti-inflammatory effects were evaluated.<br />Methods: Spirulina platensis PCST5 was cultured in a sterile Zarouk medium at 27°C and 16/8h of light/ dark exposure cycle for 25 days. Then, the polysaccharide content of biomass and cell-free culture medium samples (BPSs and CFPSs, respectively) was partially purified. The analgesic and anti-inflammatory effects were evaluated using animal models.<br />Results: 16S rRNA gene analysis confirmed that the organism was genetically similar to Spirulina platensis . The CFPSs (30 and 100 mg/kg) and BPSs (30 mg/kg) significantly reduced pain-related behaviors in rats. Similarly, all samples could significantly reduce carrageenan-induced paw inflammation volume compared with the control group. Our results suggest Spirulina 's polysaccharide fractions (CFPSs and BPSs) had significant analgesic and anti-inflammatory effects.<br />Conclusions: Since Spirulina is a readily available source of bioactive compounds, finding such potent anti-inflammatory and anti-nociceptive compounds can provide promising leads for novel drug development.<br />Competing Interests: The Authors declared that they had no conflict of interest.<br /> (Copyright © 2023, Dehghanizadeh Baghdadabad et al.)

Details

Language :
English
ISSN :
1726-6890
Volume :
22
Issue :
1
Database :
MEDLINE
Journal :
Iranian journal of pharmaceutical research : IJPR
Publication Type :
Academic Journal
Accession number :
38116564
Full Text :
https://doi.org/10.5812/ijpr-136661